Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
Oncology
Prevalence
75.0 / 100K
Incidence
23.0 / 100K/yr
0 drugs in development·0 companies·7 clinical trials
Frequently asked questions
How many clinical trials target Pathologic Stage IIIB Cutaneous Melanoma AJCC v8?
There are 7 clinical trials targeting Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 tracked by BioSniper.
What is the prevalence of Pathologic Stage IIIB Cutaneous Melanoma AJCC v8?
The estimated prevalence of Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 is approximately 75.0 per 100,000 population.
Deep-dive into Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis